DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers

Montrouge, France, May 10, 2023 DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers The New England... | June 16, 2023

Related Keywords

United States ,France ,Montrouge ,France General ,Australia ,American ,America ,Trialdataevaluating Viaskin ,Matthew Greenhawt ,Kenneth Mendez ,Angela Marcucci ,Katie Matthews ,Exchange Commission ,Allergy Foundation Of America ,Company Adss ,Announces New England Journal ,Medicine Publication ,Dataevaluating Viaskin ,New England Journal ,Viaskin Peanut ,Nasdaq Stock Market ,Daniel Tass ,Chief Executive Officer ,Hospital Colorado ,Allergy Foundation ,North America ,North American ,Basking Ridge ,Euronext Paris ,Nasdaq Global Select Market ,Des March ,Peanut Allergy ,England Journal ,